cephalosporin c has been researched along with Alloxan Diabetes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, QZ; Zhang, CL | 1 |
Ball, JG; Rogers, BA; Valentovic, MA | 1 |
Abruzzo, GK; Bland, JA; Fromtling, RA; Gadebusch, HH; Gilfillan, EC; Hadley, SK; Pelak, BA; Weissberger, BA | 1 |
3 other study(ies) available for cephalosporin c and Alloxan Diabetes
Article | Year |
---|---|
[The pharmacokinetics and pharmacodynamics of cefotaxime in experimental diabetic rats].
Topics: Animals; Cefotaxime; Cephalosporins; Diabetes Mellitus, Experimental; Male; Pneumococcal Infections; Rats; Rats, Sprague-Dawley | 1995 |
Comparison of cephaloridine renal accumulation and urinary excretion between normoglycemic and diabetic animals.
Topics: Animals; Cephaloridine; Cephalosporins; Diabetes Mellitus, Experimental; Kidney; Male; Rats; Rats, Inbred F344 | 1996 |
L-658,310, a new injectable cephalosporin. III. Experimental chemotherapeutics and pharmacokinetics in laboratory animals.
Topics: Animals; Bacterial Infections; Ceftazidime; Cephalosporins; Diabetes Mellitus, Experimental; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; Gentamicins; Half-Life; Isoindoles; Macaca mulatta; Male; Mice; Neutropenia; Pseudomonas Infections | 1989 |